JP Stock MarketDetailed Quotes

4875 MediciNova

Watchlist
  • 230
  • +1+0.44%
20min DelayTrading Jul 5 10:18 JST
11.28BMarket Cap-9593P/E (Static)

MediciNova Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.74%-3.87M
42.45%-7.43M
87.55%-499.06K
49.58%-1.37M
2.97%-2.38M
14.78%-3.18M
-37.63%-12.91M
-10.11%-4.01M
9.80%-2.72M
-317.93%-2.46M
Net income from continuing operations
5.59%-2.75M
39.08%-8.57M
31.40%-2.06M
80.20%-723.11K
28.72%-2.87M
13.85%-2.92M
-38.83%-14.07M
-44.08%-3M
-2.04%-3.65M
5.96%-4.03M
Operating gains losses
----
266.91%449.38K
--346.49K
--371
--0
--102.51K
42,723.43%122.48K
----
----
----
Depreciation and amortization
30.33%5.35K
14.62%20.3K
26.81%5.49K
27.90%5.7K
11.30%5K
-7.32%4.11K
-32.28%17.71K
-32.05%4.33K
-37.79%4.46K
-27.07%4.49K
Remuneration paid in stock
-46.58%215.43K
10.61%710.71K
-284.51%-237.41K
38.44%219.14K
18.65%325.71K
397.53%403.26K
-62.59%642.52K
117.00%128.67K
-72.66%158.3K
-63.69%274.5K
Other non cashItems
-0.26%49.39K
-473.04%-151.89K
-236.61%-298.09K
70.60%47.56K
-12.61%49.12K
9.61%49.52K
-81.21%40.72K
-265.97%-88.56K
-47.15%27.88K
2.73%56.22K
Change In working capital
-68.91%-1.38M
-66.48%111.99K
248.71%1.74M
-224.25%-921.22K
-91.20%108.98K
-73.35%-819.31K
127.66%334.1K
-36.51%-1.17M
1,084.29%741.4K
-73.06%1.24M
-Change in prepaid assets
-77.46%-551.75K
90.98%287.63K
57.12%315.11K
82.07%155.42K
-69.44%128.01K
43.90%-310.91K
199.30%150.61K
-64.24%200.55K
220.45%85.36K
745.07%418.86K
-Change in payables and accrued expense
-70.14%-781.35K
-94.15%19.24K
135.82%476.91K
-104.09%-28.8K
-96.40%30.37K
-512.43%-459.25K
132.05%329.01K
1.90%-1.33M
1,404.57%704.14K
40.07%844.76K
-Change in other current liabilities
-3.37%-50.81K
-33.92%-194.88K
-16.01%-48.48K
0.56%-47.84K
-91.54%-49.41K
-64.80%-49.15K
37.21%-145.52K
33.30%-41.79K
6.14%-48.11K
55.81%-25.8K
Cash from discontinued investing activities
Operating cash flow
-21.74%-3.87M
42.45%-7.43M
87.55%-499.06K
49.58%-1.37M
2.97%-2.38M
14.78%-3.18M
-37.63%-12.91M
-10.11%-4.01M
9.80%-2.72M
-317.93%-2.46M
Investing cash flow
Cash flow from continuing investing activities
0
199.76%39.91M
100.00%22
99.97%-2.74K
-18.58K
39.93M
-139,135.03%-40.01M
-30.01M
-340,267.60%-10M
0
Net PPE purchase and sale
----
-325.13%-21.3K
100.44%22
---2.74K
----
----
82.56%-5.01K
---5.01K
--0
----
Net investment purchase and sale
--0
199.82%39.93M
--0
--0
--0
--39.93M
---40M
---30M
---10M
--0
Cash from discontinued investing activities
Investing cash flow
--0
199.76%39.91M
100.00%22
99.97%-2.74K
---18.58K
--39.93M
-139,135.03%-40.01M
---30.01M
-340,267.60%-10M
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
0
-99.96%7.92K
0
0
Net common stock issuance
----
--0
--0
--0
----
----
-99.96%7.92K
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
----
--0
--0
--0
----
----
-99.96%7.92K
--0
--0
----
Net cash flow
Beginning cash position
175.59%51M
-74.09%18.51M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
18.98%71.43M
-30.01%52.51M
-16.14%65.23M
-11.28%67.7M
Current changes in cash
-110.53%-3.87M
161.38%32.48M
98.53%-499.04K
89.20%-1.37M
1.90%-2.4M
1,085.72%36.75M
-565.43%-52.91M
-844.71%-34.01M
-359.39%-12.72M
-264.20%-2.45M
Effect of exchange rate changes
234.58%7.61K
202.75%17.27K
-186.36%-8.88K
191.95%5.38K
232.71%18.5K
131.13%2.27K
-163.31%-16.81K
76.19%10.28K
-382.67%-5.85K
-2,949.67%-13.94K
End cash Position
-14.70%47.14M
175.59%51M
175.59%51M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
-74.09%18.51M
-30.01%52.51M
-16.14%65.23M
Free cash from
-21.74%-3.87M
42.30%-7.45M
87.56%-499.04K
49.48%-1.37M
2.21%-2.4M
14.78%-3.18M
-37.26%-12.92M
-10.25%-4.01M
9.89%-2.72M
-323.04%-2.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.74%-3.87M42.45%-7.43M87.55%-499.06K49.58%-1.37M2.97%-2.38M14.78%-3.18M-37.63%-12.91M-10.11%-4.01M9.80%-2.72M-317.93%-2.46M
Net income from continuing operations 5.59%-2.75M39.08%-8.57M31.40%-2.06M80.20%-723.11K28.72%-2.87M13.85%-2.92M-38.83%-14.07M-44.08%-3M-2.04%-3.65M5.96%-4.03M
Operating gains losses ----266.91%449.38K--346.49K--371--0--102.51K42,723.43%122.48K------------
Depreciation and amortization 30.33%5.35K14.62%20.3K26.81%5.49K27.90%5.7K11.30%5K-7.32%4.11K-32.28%17.71K-32.05%4.33K-37.79%4.46K-27.07%4.49K
Remuneration paid in stock -46.58%215.43K10.61%710.71K-284.51%-237.41K38.44%219.14K18.65%325.71K397.53%403.26K-62.59%642.52K117.00%128.67K-72.66%158.3K-63.69%274.5K
Other non cashItems -0.26%49.39K-473.04%-151.89K-236.61%-298.09K70.60%47.56K-12.61%49.12K9.61%49.52K-81.21%40.72K-265.97%-88.56K-47.15%27.88K2.73%56.22K
Change In working capital -68.91%-1.38M-66.48%111.99K248.71%1.74M-224.25%-921.22K-91.20%108.98K-73.35%-819.31K127.66%334.1K-36.51%-1.17M1,084.29%741.4K-73.06%1.24M
-Change in prepaid assets -77.46%-551.75K90.98%287.63K57.12%315.11K82.07%155.42K-69.44%128.01K43.90%-310.91K199.30%150.61K-64.24%200.55K220.45%85.36K745.07%418.86K
-Change in payables and accrued expense -70.14%-781.35K-94.15%19.24K135.82%476.91K-104.09%-28.8K-96.40%30.37K-512.43%-459.25K132.05%329.01K1.90%-1.33M1,404.57%704.14K40.07%844.76K
-Change in other current liabilities -3.37%-50.81K-33.92%-194.88K-16.01%-48.48K0.56%-47.84K-91.54%-49.41K-64.80%-49.15K37.21%-145.52K33.30%-41.79K6.14%-48.11K55.81%-25.8K
Cash from discontinued investing activities
Operating cash flow -21.74%-3.87M42.45%-7.43M87.55%-499.06K49.58%-1.37M2.97%-2.38M14.78%-3.18M-37.63%-12.91M-10.11%-4.01M9.80%-2.72M-317.93%-2.46M
Investing cash flow
Cash flow from continuing investing activities 0199.76%39.91M100.00%2299.97%-2.74K-18.58K39.93M-139,135.03%-40.01M-30.01M-340,267.60%-10M0
Net PPE purchase and sale -----325.13%-21.3K100.44%22---2.74K--------82.56%-5.01K---5.01K--0----
Net investment purchase and sale --0199.82%39.93M--0--0--0--39.93M---40M---30M---10M--0
Cash from discontinued investing activities
Investing cash flow --0199.76%39.91M100.00%2299.97%-2.74K---18.58K--39.93M-139,135.03%-40.01M---30.01M-340,267.60%-10M--0
Financing cash flow
Cash flow from continuing financing activities 000-99.96%7.92K00
Net common stock issuance ------0--0--0---------99.96%7.92K--0--0----
Cash from discontinued financing activities
Financing cash flow ------0--0--0---------99.96%7.92K--0--0----
Net cash flow
Beginning cash position 175.59%51M-74.09%18.51M-1.90%51.51M-18.94%52.88M-18.37%55.26M-74.09%18.51M18.98%71.43M-30.01%52.51M-16.14%65.23M-11.28%67.7M
Current changes in cash -110.53%-3.87M161.38%32.48M98.53%-499.04K89.20%-1.37M1.90%-2.4M1,085.72%36.75M-565.43%-52.91M-844.71%-34.01M-359.39%-12.72M-264.20%-2.45M
Effect of exchange rate changes 234.58%7.61K202.75%17.27K-186.36%-8.88K191.95%5.38K232.71%18.5K131.13%2.27K-163.31%-16.81K76.19%10.28K-382.67%-5.85K-2,949.67%-13.94K
End cash Position -14.70%47.14M175.59%51M175.59%51M-1.90%51.51M-18.94%52.88M-18.37%55.26M-74.09%18.51M-74.09%18.51M-30.01%52.51M-16.14%65.23M
Free cash from -21.74%-3.87M42.30%-7.45M87.56%-499.04K49.48%-1.37M2.21%-2.4M14.78%-3.18M-37.26%-12.92M-10.25%-4.01M9.89%-2.72M-323.04%-2.46M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg